Ancera

About:

Ancera is a biotech company focused on the business of rapid cell separation and pathogen diagnostics.

Website: http://ancera.com/

Top Investors: Connecticut Innovations, LaunchCapital, PSSI, Bulldog Innovation Group LLC, Glass Capital Management

Description:

Ancera is focused on engineering simple, practical, rapid, and cost-effective diagnostics products that can cause a revolutionary change to the quality of service provided to the end-user. The company's PIPER platform, enables near real-time, rapid detection and quantification of microbial threats across all points in the food production process, from farm-to-consumer. Their flagship product is a rapid, labor- and label-free cell sorter and immunoassay. It is capable of cell sorting, concentration, manipulation, and detection of clinically significant samples (>1cc) in <10 minutes. Their device has high sensitivity and specificity and does not require any sample preparation, handling, or incubation. Ancera offers an integrated solution capable of label-free sorting, microscopy, enumeration, assaying, and recovery of cells directly from complex food sources. They monitor and assess microbial data to provide meaningful operational and food security outcomes for the food industry.